Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to understand what the study involves and are willing to sign a consent form.
- Women aged between 18 and 64 years old.
- People who are available to attend exercise sessions as part of the study.
- People who are willing and able to attend scheduled appointments, follow a specific nutrition plan, and complete required tests.
- People who have been diagnosed with a specific type of uterine (womb) cancer called endometrioid-type endometrial cancer, confirmed through a biopsy.
- People who have a normal heart tracing (ECG) result.
- People who have not yet received any cancer treatment.
- People with a body mass index (BMI) above 20 kg/m² (a standard measure of body weight relative to height).
- People who have had a CT scan available for review.
- People who are planned to have staging surgery (an operation to assess how far the cancer has spread).
Who may not be able to join:
- People whose cancer has reached an advanced stage, specifically stage IVB under internationally recognised staging guidelines (FIGO 2018).
- People who have had, or currently have, another type of cancer — except for certain common skin cancers that are not melanoma.
- People with high blood pressure that is not well controlled by treatment.
- People with reduced kidney function, based on a specific blood test result (confirm with trial site).
- People with psychiatric conditions that are not well controlled, including a fear of enclosed spaces (claustrophobia).
- People who currently have an active infection.
- People who have an autoimmune disease (where the immune system mistakenly attacks the body).
- People who have a disease affecting the muscles or nerves.
- People for whom physical exercise is medically inadvisable for any reason.
- People in vulnerable living situations, such as homelessness or incarceration, that may make it difficult to follow the study's diet and attendance requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Denisse Castro Eguiluz, PhD, Ministry of Science, Humanities and Technology (SECIHTI)-National Cancer Institute.
Phone: +52 55 4194 0650
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in serum tyrosine concentration after the physical activity plus diet intervention, compared to patients receiving diet only.; Changes in serum histidine concentration after the physical activity plus diet intervention, compared to patients receiving diet only.; Changes in serum lysine concentration after the physical activity plus diet intervention, compared to patients receiving diet only.; Changes in serum phenylalanine concentration after the physical activity plus diet intervention, compared to patients receiving diet only.; Changes in serum glutamic acid concentration after the p...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.